Chester Springs, PA, United States of America

Robert E McKean

USPTO Granted Patents = 14 

 

Average Co-Inventor Count = 5.2

ph-index = 6

Forward Citations = 130(Granted Patents)


Location History:

  • West Chester, PA (US) (2011)
  • Chester Springs, PA (US) (2013 - 2019)

Company Filing History:


Years Active: 2011-2019

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Robert E McKean

Introduction

Robert E McKean is a prominent inventor based in Chester Springs, Pennsylvania, known for his significant contributions to the field of pharmaceuticals. With an impressive portfolio of 14 patents, McKean has made a remarkable impact on drug formulation, particularly in the area of solid forms of bendamustine hydrochloride.

Latest Patents

Among McKean’s latest innovations are novel solid forms of bendamustine hydrochloride. These patents detail innovative methods for their preparation and use, enhancing the effectiveness and usability of this important pharmaceutical compound. His work in this area underscores his dedication to advancing healthcare solutions.

Career Highlights

Throughout his career, Robert E McKean has worked with notable companies, including Cephalon, Inc. and Ignyta, Inc. His roles in these organizations have allowed him to collaborate with leading experts in the field and to turn innovative ideas into tangible products that benefit patients.

Collaborations

McKean has collaborated with esteemed professionals such as Laurent D Courvoisier and Mark D Eddleston. These partnerships have played a pivotal role in enhancing the research and development processes, fostering a collaborative environment that drives innovation forward.

Conclusion

Robert E McKean exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through numerous patents not only demonstrate his expertise but also reflect his commitment to improving medical therapies. As the field continues to evolve, McKean’s work will undoubtedly leave a lasting legacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…